Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Synergistic Real-World Study and Evidence-based Medicine Evaluation of Elemene Combined With Tyrosine Kinase Inhibitors（TKIs）in the Treatment of Advanced Non-small Cell Lung Cancer (NSCLC): Prospective Study

NCT04401059 is registered in ClinicalTrials.gov with Tian Xie as lead sponsor.

NCT NCT04401059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04401059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Synergistic Real-World Study and Evidence-based Medicine Evaluation of Elemene Combined With Tyrosine Kinase Inhibitors（TKIs）in the Treatment of Advanced Non-small Cell Lung Cancer (NSCLC): Prospective Study
Lead sponsor
Tian Xie
Phase
Phase 4
Overall status
Unknown status
Start date
November 9, 2020
Completion date
March 30, 2026
Enrollment
744 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma, carcinoma, non-small-cell lung cancer